[HTML][HTML] Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic …
ME Dudley, JR Wunderlich, JC Yang… - Journal of clinical …, 2005 - ncbi.nlm.nih.gov
Journal of clinical oncology: official journal of the American Society …, 2005•ncbi.nlm.nih.gov
Adoptive Cell Transfer Therapy Following Non-Myeloablative but Lymphodepleting
Chemotherapy for the Treatment of Patients With Refractory Metastatic Melanoma - PMC
Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI
Homepage Main Content Main Navigation Search PMC Full-Text Archive Search in PMC
Advanced Search User Guide Journal List HHS Author Manuscripts PMC1475951 Other
Formats PDF (1.3M) Actions Cite Collections Share Permalink Copy RESOURCES Similar …
Chemotherapy for the Treatment of Patients With Refractory Metastatic Melanoma - PMC
Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI
Homepage Main Content Main Navigation Search PMC Full-Text Archive Search in PMC
Advanced Search User Guide Journal List HHS Author Manuscripts PMC1475951 Other
Formats PDF (1.3M) Actions Cite Collections Share Permalink Copy RESOURCES Similar …
Abstract
Purpose
We investigated the combination of lymphodepleting chemotherapy followed by the adoptive transfer of autologous tumor reactive lymphocytes for the treatment of patients with refractory metastatic melanoma.
ncbi.nlm.nih.gov